In melanomas, the expression of PD-L1 within tumours was considered a prognostic marker [26,27], and treatment with PD-L1 antibodies in hepatocellular carcinoma reduced the escape of liver tumour cells [28]. This evidence concerns the gene CD274 and neoplasm.